Charlottesville, VA, United States of America

Karina Teixeira

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Virginia Patent Foundation. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Karina Teixeira in Insulin Secretion and Islet Viability

Introduction

Karina Teixeira is an accomplished inventor based in Charlottesville, VA (US). She has made significant contributions to the field of biomedical research, particularly in the area of insulin secretion and pancreatic islet viability. Her work has the potential to impact the treatment of diabetes and related conditions.

Latest Patents

Karina Teixeira holds a patent for "Compositions and methods for promoting islet viability and enhancing insulin secretion." This patent encompasses various compositions and methods aimed at regenerating pancreatic islet viability and enhancing insulin secretion in vitro, ex vivo, and in vivo. The patent also addresses the prevention of rejection of transplanted islets and offers solutions for treating conditions associated with abnormal insulin responsiveness to glucose. The compositions may include peptides or pharmaceutically acceptable salts, with specific amino acid sequences outlined in the patent.

Career Highlights

Karina is associated with the University of Virginia Patent Foundation, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving health outcomes through scientific discovery and innovation.

Collaborations

Throughout her career, Karina has collaborated with notable colleagues, including Gordon W. Laurie and Preeti Chhabra. These collaborations have further enriched her research and contributed to the development of her patented technologies.

Conclusion

Karina Teixeira's innovative work in promoting islet viability and enhancing insulin secretion represents a significant advancement in diabetes research. Her contributions are poised to make a lasting impact on the field and improve the lives of those affected by insulin-related disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…